| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |